Company Quick10K Filing
Newbridge Global Ventures
10-Q 2019-06-30 Filed 2019-10-15
10-Q 2019-03-31 Filed 2019-07-11
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-12-27
10-Q 2018-06-30 Filed 2018-08-14
S-1 2018-04-27 Public Filing
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-06
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-08
10-Q 2016-03-31 Filed 2016-05-16
10-Q 2015-09-30 Filed 2015-11-20
10-K 2015-06-30 Filed 2015-09-30
10-Q 2015-03-31 Filed 2015-05-14
10-Q 2014-12-31 Filed 2015-02-12
10-Q 2014-09-30 Filed 2014-11-14
10-K 2014-06-30 Filed 2014-10-20
10-Q 2014-03-31 Filed 2014-05-20
10-Q 2013-12-31 Filed 2014-02-14
10-Q 2013-09-30 Filed 2013-11-14
10-K 2013-06-30 Filed 2013-10-15
10-Q 2013-03-31 Filed 2013-05-08
10-Q 2012-12-31 Filed 2013-02-22
10-Q 2012-09-30 Filed 2012-11-14
10-K 2012-06-30 Filed 2012-09-21
10-Q 2012-03-31 Filed 2012-05-16
10-Q 2011-12-31 Filed 2012-01-19
10-Q 2011-09-30 Filed 2011-10-14
10-K 2011-06-30 Filed 2011-07-22
10-Q 2011-03-31 Filed 2011-05-03
10-Q 2010-12-31 Filed 2011-02-14
10-Q 2010-09-30 Filed 2010-11-19
10-K 2010-06-30 Filed 2010-09-30
10-Q 2010-03-31 Filed 2010-05-14
10-Q 2009-12-31 Filed 2010-02-03
8-K 2020-09-30
8-K 2020-07-01
8-K 2020-03-10
8-K 2020-02-28
8-K 2019-12-09
8-K 2019-10-21
8-K 2019-10-18
8-K 2019-09-10
8-K 2019-09-03
8-K 2019-08-30
8-K 2019-08-28
8-K 2019-08-27
8-K 2019-06-26
8-K 2019-06-06
8-K 2019-05-13
8-K 2019-05-02
8-K 2019-05-01
8-K 2019-04-17
8-K 2019-04-16
8-K 2019-04-12
8-K 2019-02-21
8-K 2019-01-17
8-K 2019-01-15
8-K 2018-10-19
8-K 2018-10-05
8-K 2018-09-24
8-K 2018-09-14
8-K 2018-08-31
8-K 2018-07-26
8-K 2018-07-16
8-K 2018-07-12
8-K 2018-06-18
8-K 2018-05-08
8-K 2018-04-20
8-K 2018-03-05
8-K 2018-02-19
8-K 2018-02-06

Newbridge Global Ventures Financials

NBGV Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-06-30
Cash71028751253544168312521991,1336771044131,403931663246201,25790198
Accounts Receivable
Inventory
PP&E25333332313004,2195,4609,184
Assets4324146364011,7561,4711,3491,2711,244132161911324074791,3148561,6213,9144,2102,6682,62834712621414,63714,60022,306
Accounts Payable8375321671786210915715891152232121931109147264263283754384762257412,522
Long-Term Debt353327217341,875
Liabilities2082231813071,8621,7131,8962,1522,3783302491231261151653902882,5552,5992,0772,5501801151725451,8142,8549,397
Stockholders' Equity22419145694-107-241-547-881-1,134-198-2336762914631,2617661,3341,3591,61059079167-104-167-33112,82311,74612,364
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-06-30
Revenue110190100
Cost of Revenue
Gross Profit
R&D
SG&A564053-3852511671754993291,655851801433971872295288119001,4278847542558375101,1642,7164,017
Tax00000000000
Net Income-48-34-53-520-256-926-345-578-399-2,177-85130-148-405-188-528-811-1,003-1,697-1,166-1,098-1,104-832-491-472-2,104-4,397
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-06-30
Cash Operating-22-20-53-450-48-87-24-23-54-70-222-86-187-132-246-488-924-1,812-685-1,470-750-31247-154-131-401
Cash Investing2223-262127222912900000-915
Cash Financing34017067640025-47290128653291,069361,706211-751561452,558